FDA grants breakthrough nod for Carthera's SonoCloud-9
Carthera announced today that it received FDA breakthrough device designation for its implantable SonoCloud-9 system.
Source: massdevice.com
Stay updated with breaking news from Michael Canney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Carthera announced today that it received FDA breakthrough device designation for its implantable SonoCloud-9 system.
Paris, France, June 9, 2021 – CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces preclinical results in the testing of the combination of SonoCloud® technology with immunotherapies. This laboratory work was done in collaboration...